Clinical Trial Update: Combined Administration of Nebulized Amikacin in Patients With Acute Exacerbation of Non-Cystic Fibrosis Bronchiectasis [Phase 4]

View source ↗

Summary

Phase 4 clinical trial evaluating nebulized amikacin in acute exacerbation of non-Cystic Fibrosis bronchiectasis has completed with posted results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-cystic Fibrosis Bronchiectasis

Drugs mentioned

• Amikacin (nebulized) (amikacin)

Snippet

Sponsor: Qilu Hospital of Shandong University | Conditions: Non-Cystic Fibrosis Bronchiectasis | Phase 4 | Status: COMPLETED | Results posted: 2019-04-16